Characterization of Austrian severe asthma patients
Introduction - The Severe Asthma Registry, founded by German Asthma Net (GAN) in 2011, is a prospective registry recording clinical parameters from participating centers in Germany, Austria and Switzerland. This article presents the baseline characteristics of severe asthma patients from Austrian ce...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
10 October 2023
|
| In: |
Respiratory medicine
Year: 2023, Jahrgang: 219, Pages: 1-8 |
| ISSN: | 1532-3064 |
| DOI: | 10.1016/j.rmed.2023.107427 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.1016/j.rmed.2023.107427 Verlag, kostenfrei, Volltext: https://www.sciencedirect.com/science/article/pii/S0954611123003153 
|
| Verfasserangaben: | Andreas Renner, Slagjana Stoshikj, Wolfgang Pohl, Christina Bal, Matthias Reisinger, Judith Löffler-Ragg, Angela Zacharasiewicz, Roland Buhl, Eckard Hamelmann, Christian Taube, Stephanie Korn, Marco Idzko |
| Zusammenfassung: | Introduction - The Severe Asthma Registry, founded by German Asthma Net (GAN) in 2011, is a prospective registry recording clinical parameters from participating centers in Germany, Austria and Switzerland. This article presents the baseline characteristics of severe asthma patients from Austrian centers. - Methods - We analyzed the baseline visit data of all patients recruited to the GAN Severe Asthma Registry from participating Austrian centers. - Results - Baseline visit data were available for 214 Austrian severe asthma patients from 6 Austrian centers from 2013 to 2022. Mean age was 53.7 years. Mean BMI was 26.4 kg/m2. More than a third (37.4%) of all patients had daily daytime asthma symptoms at baseline and had to use their reliever medication at least once per day. Forty-one percent of patients were classified as uncontrolled according to GINA and 24.8% as partially controlled at baseline visit. The median annual exacerbation frequency was 3 in the previous 12 months. At the time of baseline visit, 23.4% of all patients had regular treatment with oral corticosteroids. Furthermore, 23.9% had received any severe asthma monoclonal antibody prior to the baseline visit. There were no notable differences in baseline characteristics between patients categorized by smoking history or measurable type 2 inflammation. - Conclusions - This study provides the first multi-center characterization of Austrian severe asthma patients. Patients in this cohort had better asthma control and less frequent exacerbations compared to most international registries. |
|---|---|
| Beschreibung: | Gesehen am 18.03.2024 |
| Beschreibung: | Online Resource |
| ISSN: | 1532-3064 |
| DOI: | 10.1016/j.rmed.2023.107427 |